1. Home
  2. VALN vs HBCP Comparison

VALN vs HBCP Comparison

Compare VALN & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • HBCP
  • Stock Information
  • Founded
  • VALN 2012
  • HBCP 1908
  • Country
  • VALN France
  • HBCP United States
  • Employees
  • VALN N/A
  • HBCP N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • HBCP Banks
  • Sector
  • VALN Health Care
  • HBCP Finance
  • Exchange
  • VALN Nasdaq
  • HBCP Nasdaq
  • Market Cap
  • VALN 345.2M
  • HBCP 398.8M
  • IPO Year
  • VALN 2021
  • HBCP 2008
  • Fundamental
  • Price
  • VALN $4.36
  • HBCP $46.51
  • Analyst Decision
  • VALN Strong Buy
  • HBCP Buy
  • Analyst Count
  • VALN 2
  • HBCP 2
  • Target Price
  • VALN $18.50
  • HBCP $46.50
  • AVG Volume (30 Days)
  • VALN 68.4K
  • HBCP 25.4K
  • Earning Date
  • VALN 11-07-2024
  • HBCP 01-27-2025
  • Dividend Yield
  • VALN N/A
  • HBCP 2.24%
  • EPS Growth
  • VALN N/A
  • HBCP N/A
  • EPS
  • VALN N/A
  • HBCP 4.51
  • Revenue
  • VALN $176,817,979.00
  • HBCP $130,219,000.00
  • Revenue This Year
  • VALN $24.66
  • HBCP N/A
  • Revenue Next Year
  • VALN $9.67
  • HBCP $4.77
  • P/E Ratio
  • VALN N/A
  • HBCP $10.31
  • Revenue Growth
  • VALN N/A
  • HBCP N/A
  • 52 Week Low
  • VALN $3.62
  • HBCP $33.30
  • 52 Week High
  • VALN $9.50
  • HBCP $52.39
  • Technical
  • Relative Strength Index (RSI)
  • VALN 48.76
  • HBCP 51.75
  • Support Level
  • VALN $4.22
  • HBCP $44.75
  • Resistance Level
  • VALN $4.51
  • HBCP $46.33
  • Average True Range (ATR)
  • VALN 0.21
  • HBCP 1.37
  • MACD
  • VALN 0.00
  • HBCP 0.19
  • Stochastic Oscillator
  • VALN 41.90
  • HBCP 89.82

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.

Share on Social Networks: